Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04474353
What this trial is testing

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed Glioblastoma
Stanford University 12
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Early research (Phase 1)Ended earlyNCT05571839
What this trial is testing

PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerColorectal Neoplasms+2 more
Seagen, a wholly owned subsidiary of Pfizer 41
Testing effectiveness (Phase 2)UnknownNCT00108875
What this trial is testing

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Who this might be right for
Malignant MelanomaPancreatic CancerColon Cancer+1 more
Julius-Maximilians University 70
Early research (Phase 1)Study completedNCT02285101
What this trial is testing

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

Who this might be right for
MelanomaProstate Adenocarcinoma
Bio-Cancer Treatment International Limited 23
Early research (Phase 1)Study completedNCT00024557
What this trial is testing

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 40
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Study completedNCT00003688
What this trial is testing

Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia

Who this might be right for
Gestational Trophoblastic Tumor
Gynecologic Oncology Group
Not applicableLooking for participantsNCT04699773
What this trial is testing

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

Who this might be right for
GliomaGlioblastomaBrain Tumor
University of Maryland, Baltimore 32
Not applicableUnknownNCT06207747
What this trial is testing

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

Who this might be right for
MelanomaPET CT
Institute of Oncology Ljubljana 70
Not applicableStudy completedNCT03663647
What this trial is testing

Advanced Melanoma in Russian Experience

Who this might be right for
Cutaneous Melanoma, Stage IVBRAF V600 Mutation
MelanomaPRO, Russia 382
Not applicableUnknownNCT04851925
What this trial is testing

MR Fingerprinting for Vestibular Schwannomas

Who this might be right for
Vestibular Schwannoma
Medical University of Vienna 50
Not applicableLooking for participantsNCT06055517
What this trial is testing

Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)

Who this might be right for
Glioma
Centro di Riferimento Oncologico - Aviano 29
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Testing effectiveness (Phase 2)Study completedNCT04801147
What this trial is testing

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 76
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)Ended earlyNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT00062855
What this trial is testing

Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Baylor College of Medicine 9
Not applicableWithdrawnNCT01003626
What this trial is testing

Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients

Who this might be right for
Advanced CancersMelanoma
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT03722355
What this trial is testing

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Who this might be right for
GliomaGlioblastoma MultiformeAstrocytoma
Radiation Therapy Oncology Group 712
Next Page